EFFECT OF ORAL COENZYME-Q10 SUPPLEMENTATION ON THE OXIDATION RESISTANCE OF HUMAN VLDL- ABSORPTION AND ANTIOXIDATIVE PROPERTIES OF OIL AND GRANULE-BASED PREPARATIONS(LDL FRACTION )
J. Kaikkonen et al., EFFECT OF ORAL COENZYME-Q10 SUPPLEMENTATION ON THE OXIDATION RESISTANCE OF HUMAN VLDL- ABSORPTION AND ANTIOXIDATIVE PROPERTIES OF OIL AND GRANULE-BASED PREPARATIONS(LDL FRACTION ), Free radical biology & medicine, 22(7), 1997, pp. 1195-1202
Coenzyme Q10 (Q10) is supposed to be an important endogenous lipid-sol
uble antioxidant. We studied 60 healthy 46 +/- 7 (mean +/- SD)-year-ol
d smoking men. They were randomized into three groups to receive oil-b
ased or granular Q10 (90 mg/d) or placebo for 2 months. Oil-based caps
ule elevated Q10 in plasma by 178% and in VLDL+LDL fraction by 160%. T
he granular preparation increased Q10 in plasma by 168% and in VLDL+LD
L by 127%. However, the 2-month Q10 supplementation did not increase t
he oxidation resistance of VLDL+LDL fraction, as assessed by copper in
duced VLDL+LDL oxidation, haemin+H2O2-induced VLDL+LDL oxidation, tota
l antioxidative capacity of LDL, and plasma malondialdehyde measuremen
ts. The first and the last dose was used to carry out a 12 h pharmacok
inetic study (five subjects per group), which indicated that only a sm
all part of supplemented Q10 was absorbed to the circulation in 12 h a
nd that the absorption varied extensively between subjects. Our result
s suggest that at least among smoking men, 90 mg of orally supplemente
d Q10 daily does not increase the oxidation resistance of VLDL+LDL. Bi
oavailability of both the granular and the oil-based Q10 preparation w
as similar during the long-term supplementation, but one dose of 30 mg
had only a marginal effect on the plasma levels of Q10. (C) 1997 Else
vier Science Inc.